AHL
BOLD

Abel Hall LLC’s Boundless Bio BOLD Stock Holding History

Abel Hall LLC’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,865
Closed -$15.4K – 987
2025
Q4 		$15.4K Sell
12,865
-60
-0.5% -$75 ﹤0.01% 706
2025
Q3 		$15.9K Sell
12,925
-1,474
-10% -$1.7K 0.01% 317
2025
Q2 		$14.5K Buy
+14,399
New +$19.1K 0.01% 275

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Abel Hall LLC's BOLD Position: Q1 2026 in Review

Abel Hall LLC sold out of Boundless Bio (BOLD) in Q1 2026, closing a stake of 12,865 shares — an estimated $15.4K sold.

Abel Hall LLC first reported a position in BOLD in Q2 2025 and held it in 3 quarters. The position peaked at $15.9K in Q3 2025. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Abel Hall LLC reported no remaining Boundless Bio position as of Q1 2026 after selling out during the quarter.
  • Abel Hall LLC sold 12,865 Boundless Bio shares in Q1 2026, an estimated $15.4K.
  • Abel Hall LLC first reported a position in Boundless Bio in Q2 2025 and held it in 3 quarters.
  • Abel Hall LLC's Boundless Bio position peaked at $15.9K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.